FDA Brushes Up On Committee Transparency
Some of those guidelines contained advice for how the committees could best generate discussion among members. Committee members should be given thorough, helpful briefing materials before meetings, and at meetings all members' views should be solicited before voting has begun in order to guarantee a consistent understanding of issues presented, the FDA said....
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login